Dyadic International starts dosing in Phase 1 clinical trial DYAI-100 booster vaccine candidate

By Proactive Investors / January 27, 2023 / www.youtube.com / Article Link


Dyadic International CEO Mark Emalfarb and Chief Business Officer Joe Hazelton joined Steve Darling from Proactive to share ...

Recent News

Market still expecting strong growth for major gold producers

July 27, 2026 / www.canadianminingreport.com

Newmont starts Q2/26 strong, growth expected for gold majors

July 27, 2026 / www.canadianminingreport.com

Gold not the consensus play anymore

July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year

July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities

July 14, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok